Radicava 30 mg in 100 mL Injection
RxNorm 1924317
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1924317 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Radicava 30 mg in 100 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
100 mL edaravone 0.3 mg/ML Injection [Radicava]
(Atom ID: 9186438)
SYPrescribable
Synonym (SY):
100 mL Radicava 0.3 mg/ML Injection
(Atom ID: 9186439)
PSNPrescribable
Prescribable Name (PSN):
Radicava 30 mg in 100 mL Injection
(Atom ID: 9179941)
SYPrescribable
Synonym (SY):
Radicava 30 mg per 100 mL Injection
(Atom ID: 9179943)
Patient Education
Edaravone Injection
Edaravone injection is used to treat amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease; a condition in which the nerves that control muscle movement slowly die, causing the muscles to shrink and weaken). Edaravone injection is in a class of medications called antioxidants. It may work to slow the nerve damage associated with the worsening of ALS symptoms.
[Learn More]
* Please review the disclaimer below.